Minsheng Securities·2025-07-31 12:42Market Overview - The market continued to rise in July, supported by both policy and liquidity[5] - Policies aimed at "anti-involution" have led to higher elasticity in commodity prices, driving cyclical industries to lead the market[5] - Future focus will remain on liquidity support and the gradual increase in risk appetite, although the likelihood of market adjustments is rising[5] Investment Recommendations - The "Golden Stock Portfolio" has achieved a year-to-date return of 30.37%[15] - Key recommended stocks include: - China Pacific Insurance (601601.SH) - Innovent Biologics (1801.HK) - Bairun Food (002568.SZ) - Muyuan Foods (002714.SZ) - Filihua (300395.SZ) - CATL (300750.SZ) - Hubei Yihua (000422.SZ) - Luoyang Molybdenum (603993.SH) - Conch Cement (600585.SH) - North Huachuang (002371.SZ)[12] Risk Factors - Risks include macroeconomic performance falling short of expectations, policy implementation delays, and overseas expansion not meeting projections[12]